Does the Orphan designation provide for any fast tracking of clinical trials, once the safety profile of the drug has been established?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025